Arcutis Biotherapeutics, Inc. Quarterly Current Ratio in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Arcutis Biotherapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2020 to Q2 2024.
  • Arcutis Biotherapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 809 %, a 25.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 809 -275 -25.4% Jun 30, 2024
Q1 2024 805 -341 -29.7% Mar 31, 2024
Q4 2023 794 -379 -32.3% Dec 31, 2023
Q3 2023 910 -277 -23.4% Sep 30, 2023
Q2 2023 1.08K -191 -15% Jun 30, 2023
Q1 2023 1.15K -446 -28% Mar 31, 2023
Q4 2022 1.17K -897 -43.3% Dec 31, 2022
Q3 2022 1.19K -1.04K -46.8% Sep 30, 2022
Q2 2022 1.28K -631 -33.1% Jun 30, 2022
Q1 2022 1.59K +84.5 +5.61% Mar 31, 2022
Q4 2021 2.07K +783 +60.8% Dec 31, 2021
Q3 2021 2.23K +878 +65% Sep 30, 2021
Q2 2021 1.91K Jun 30, 2021
Q1 2021 1.51K Mar 31, 2021
Q4 2020 1.29K Dec 31, 2020
Q3 2020 1.35K Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.